Predict your next investment

Holding Company
mentorcapital.com

See what CB Insights has to offer

Investments

27

Portfolio Exits

4

About Mentor Capital

Mentor Capital targets warrant proceeds for operating cancer companies often like those in the Cancer Immunotherapy Index and to invest in those or related firms via stock purchase or acquisition. The company's advantage is to seek in depth medical science judgment to screen cancer breakthroughs for probable success well in advance of the FDA process. In the Mentor program, an identified cancer company enters into a Long-term Equity Funding Agreement with the company. The company receives cancer related shares that are held in escrow until the associated investment payable is retired. The cancer fighting company receives cash from warrant proceeds at an agreed upon fixed price. The mutually related funding contracts speed up payment to the cancer companies growing most quickly.

Mentor Capital Headquarter Location

P.O. Box 1709

Ramona, California, 92065,

United States

760-788-4700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Mentor Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Mentor Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Mentor Capital News

Mentor Capital Revenues Up 15% for the 1st Quarter 2021

May 18, 2021

Trailing Revenues at 200% of Current Market Capitalization Following Texas Expansion May 18, 2021 03:06 PM Eastern Daylight Time PLANO, Texas--( BUSINESS WIRE )--Mentor Capital, Inc. (OTCQB: MNTR) announced in its 10-Q filing for the first quarter of 2021 that revenues increased 15% during the first quarter compared to the same quarter in 2020. Compared to one year earlier, trailing twelve-month revenues increased 14% to $5.0 million or 22 cents per share. The May 17, 2021 closing Mentor share price was 11 cents per share, corresponding to a current market capitalization of $2.5 million. Mentor CEO, Chet Billingsley, attributes the revenue changes to the combination of the business expansion and move into Texas, the waning of the COVID-19 impact on the economy, and new explorations into the crypto sector. In its 10-Q filing to the SEC for the quarter ending March 31, 2021, the Company reports that Mentor had revenues of $1,320,624 and gross profit of $436,392 with a resulting net loss attributable to Mentor of ($146,923) or (0.6 cents) per share. This is a betterment over the prior-year quarter ended March 31, 2020, in which Mentor had revenues of $1,149,462 and gross profit of $385,102 with a resulting net loss attributable to Mentor of ($247,770) or (1.1 cents) per share. On February 17, 2021, Mentor received a second Paycheck Protection Program loan of $76,593 from the U.S. Small Business Administration, from which the Company may apply for forgiveness. On March 31, 2021, there were 22,850,947 Company shares or share equivalents issued and outstanding. No equity was granted to directors, insiders, consultants, or investor relations firms in the first quarter of 2021. The Company's shares finished the quarter at a closing price of $0.165 per share, representing a market capitalization of $3,770,406 compared to a 2020 year-end closing price of $0.081 per share and a corresponding market capitalization of $1,850,927. The Company is managed by Chairman, CEO, and director Chet Billingsley (68), who founded Mentor Capital first as an acquisition partnership in 1985. Mr. Billingsley's interest is reported at 12.43% on a fully diluted basis as of May 14, 2021, with other directors and officers holding an additional 6.71%. The Form 10-Q may be referenced through the SEC's EDGAR system at: https://www.sec.gov/edgar/searchedgar/companysearch.html or at the Company's website: www.MentorCapital.com , where additional important information for investors can be found. About Mentor Capital: The Company seeks to come alongside and assist private companies with their founders and investors in meeting their liquidity, equity financing, and acquisition objectives. The Company is currently exploring expansion to its start in the crypto space, looking at plastics companies, expanding its existing Waste Consolidators operation into Texas, and collecting on or selling off the Company's former cannabis financings, patents, leases, and legal proceedings. This press release is neither an offer to sell nor a solicitation of offers to purchase securities. Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws and is subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events, or circumstances occurring after the date of this press release. Contacts

Mentor Capital Investments

27 Investments

Mentor Capital has made 27 investments. Their latest investment was in eShiksa as part of their Seed VC on March 3, 2019.

CBI Logo

Mentor Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/29/2019

Seed VC

eShiksa

Yes

1

9/14/2018

Unattributed - III

GFarmaLabs

$0.25M

No

1

2/12/2018

Corporate Minority

Pueblo West Organics

Yes

2

1/16/2018

Unattributed - II

Subscribe to see more

$99M

Subscribe to see more

10

5/2/2017

Loan

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/29/2019

9/14/2018

2/12/2018

1/16/2018

5/2/2017

Round

Seed VC

Unattributed - III

Corporate Minority

Unattributed - II

Loan

Company

eShiksa

GFarmaLabs

Pueblo West Organics

Subscribe to see more

Subscribe to see more

Amount

$0.25M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

2

10

10

Mentor Capital Portfolio Exits

4 Portfolio Exits

Mentor Capital has 4 portfolio exits. Their latest portfolio exit was AEP Networks on September 30, 2011.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/30/2011

Acquired

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

9/30/2011

00/00/0000

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

10

10

10

Mentor Capital Acquisitions

3 Acquisitions

Mentor Capital acquired 3 companies. Their latest acquisition was Cannabis Investor Webcast on April 22, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/22/2015

Acquired

1

3/11/2014

Subscribe to see more

$991

$99M

Subscribe to see more

10

2/20/2014

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/22/2015

3/11/2014

2/20/2014

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

Total Funding

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.